JeffreyJSwigrisDO

Pulmonology • Denver, CO

Critical Care Medicine, Pleural Disease

Associate Professor, Medicine, University of Colorado School of Medicine

Join to view full profile

Dr. Swigris is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Swigris' full profile

Already have an account?

Office
1400 Jackson St
Denver, CO 80206
Phone+1 303-388-4461

Fax+1 303-270-2206

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2000 - 2003
Cleveland Clinic FoundationResidency, Internal Medicine, 1997 - 2000
Ohio University Heritage College of Osteopathic Medicine in AthensClass of 1996

Certifications & Licensure

CO State License 2005 - 2025
CA State License 2000 - 2007
OH State License 2000 - 2000

Clinical Trials

Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis Start of enrollment: 2010 Feb 01
Completed

Publications & Presentations

PubMed

2130 citations
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis
Talmadge E. King, Williamson Z. Bradford, Socorro Castro-Bernardini, Elizabeth A. Fagan, Ian Glaspole
The New England Journal of Medicine. 2014-05-28
4037 citations
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management
Ganesh Raghu, Harold R. Collard, Jim J. Egan, Fernando J. Martinez, Juergen Behr
American Journal of Respiratory and Critical Care Medicine. 2011-03-15
138 citations
Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry.
Michael Kreuter, Jeffrey J. Swigris, David Pittrow, S Geier, Jens Klotsche
Respiratory Research. 2017-07-14

Press Mentions

Genetics of Pulmonary Fibrosis: What Is Known and What's to Come?October 23rd, 2024
Managing Complex Patients with Pulmonary Hypertension and ILDSeptember 24th, 2024
Pulmonary Fibrosis Foundation: How Patient Advocacy Is Transforming IPF Research and CareAugust 22nd, 2024
Join now to see all

Grant Support

Pulmonary Rehabilitation For Idiopathic Pulmonary FibrosisNational Heart, Lung, And Blood Institute2009–2011